Steven M Larson Selected Research

Thymidine

12/2013	Evaluation of arginine deiminase treatment in melanoma xenografts using (18)F-FLT PET.
3/2008	Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas.
9/2006	[131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven M Larson Research Topics

Disease

137	Neoplasms (Cancer) 09/2023 - 01/2002
53	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2002
25	Neoplasm Metastasis (Metastasis) 11/2022 - 02/2003
18	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 11/2002
10	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 07/2003
9	Lymphoma (Lymphomas) 01/2023 - 02/2003
8	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2006
8	Neuroblastoma 01/2020 - 03/2003
6	Rectal Neoplasms (Rectal Cancer) 08/2013 - 07/2002
5	Melanoma (Melanoma, Malignant) 09/2017 - 07/2011
4	Papillary Thyroid Cancer 06/2013 - 12/2004
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2011 - 05/2005
4	Carcinoma (Carcinomatosis) 02/2011 - 07/2003
3	Glioblastoma (Glioblastoma Multiforme) 11/2015 - 10/2012
3	Renal Cell Carcinoma (Grawitz Tumor) 05/2014 - 08/2003
3	Pain (Aches) 02/2014 - 10/2009
3	Kidney Neoplasms (Kidney Cancer) 04/2012 - 01/2003
3	Head and Neck Neoplasms (Head and Neck Cancer) 10/2008 - 05/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2003 - 01/2002
2	Peritoneal Neoplasms 01/2023 - 01/2022
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2010
2	Hepatocellular Carcinoma (Hepatoma) 03/2018 - 02/2017
2	Disease Progression 02/2018 - 02/2003
2	Glioma (Gliomas) 01/2018 - 12/2012
2	Adenocarcinoma 01/2018 - 10/2005

Drug/Important Bio-Agent (IBA)

28	AntigensIBA 01/2021 - 09/2003
20	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 03/2004
19	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2024 - 01/2002
16	Monoclonal AntibodiesIBA 11/2022 - 08/2002
16	AntibodiesIBA 01/2022 - 09/2003
14	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2005
14	Radioisotopes (Radionuclides)IBA 01/2023 - 02/2002
10	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2021 - 05/2006
9	IodineIBA 01/2023 - 10/2006
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2003
8	procaine isothiocyanate (PRIT)IBA 01/2023 - 07/2014
8	Phosphotransferases (Kinase)IBA 11/2020 - 05/2005
8	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 01/2002
8	Immunoglobulin G (IgG)IBA 01/2020 - 10/2005
7	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 10/2005
6	LigandsIBA 01/2021 - 09/2007
6	EnzymesIBA 01/2017 - 12/2005
5	RadiopharmaceuticalsIBA 09/2023 - 11/2004
5	Trastuzumab (Herceptin)FDA Link 06/2019 - 07/2003
5	Thyroglobulin FDA Link 01/2019 - 12/2004
4	omburtamab I-131IBA 11/2022 - 12/2019
4	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 12/2007
4	AcidsIBA 01/2021 - 01/2006
4	Glucose (Dextrose)FDA LinkGeneric 08/2011 - 04/2004
4	Deoxyglucose (2 Deoxy D glucose)IBA 02/2006 - 06/2002
3	Thyrotropin Alfa FDA LinkGeneric 01/2022 - 12/2004
3	Iodine-124IBA 01/2022 - 01/2008
3	lintuzumabIBA 01/2022 - 08/2002
3	IsotopesIBA 01/2021 - 08/2002
3	Peptides (Polypeptides)IBA 01/2021 - 05/2004
3	6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA 10/2020 - 09/2011
3	Chimeric Antigen ReceptorsIBA 01/2020 - 09/2007
3	Indicators and Reagents (Reagents)IBA 11/2019 - 10/2013
3	Dihydrotestosterone (Androstanolone)IBA 01/2019 - 11/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2016
3	Hormones (Hormone)IBA 01/2019 - 01/2002
3	enzalutamideIBA 02/2018 - 06/2011
3	Dextrans (Dextran)FDA Link 01/2018 - 02/2014
3	AndrogensIBA 11/2016 - 10/2009
3	IodidesIBA 11/2016 - 04/2008
3	StreptavidinIBA 07/2014 - 01/2006
3	arginine deiminaseIBA 12/2013 - 02/2012
3	ThymidineIBA 12/2013 - 09/2006
3	tanespimycin (17AAG)IBA 04/2012 - 06/2004
3	Therapeutic UsesIBA 04/2008 - 07/2006
2	LuciferasesIBA 01/2023 - 01/2022
2	Pemetrexed (MTA)FDA Link 01/2023 - 10/2006
2	human ERBB2 proteinIBA 01/2023 - 01/2018
2	VemurafenibIBA 01/2022 - 01/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 11/2015
2	Dasatinib (BMS 354825)FDA Link 11/2020 - 12/2012
2	HaptensIBA 01/2020 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2020 - 08/2011
2	Technetium Tc 99m MedronateIBA 01/2019 - 12/2010
2	Kallikreins (Kallikrein)IBA 01/2019 - 11/2016
2	Testosterone (Sustanon)FDA Link 01/2019 - 03/2004
2	codrituzumabIBA 03/2018 - 02/2017
2	Iodine-131IBA 01/2017 - 07/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 12/2011
2	Liposomes (Liposome)IBA 12/2016 - 02/2011
2	J591 monoclonal antibodyIBA 12/2016 - 05/2014
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2016 - 05/2006
2	8H9 monoclonal antibodyIBA 12/2015 - 10/2005
2	ErbB Receptors (EGF Receptor)IBA 11/2015 - 02/2011

Therapy/Procedure

74	Therapeutics 09/2023 - 01/2002
27	Radioimmunotherapy 01/2023 - 02/2003
26	Castration 01/2022 - 07/2008
18	Drug Therapy (Chemotherapy) 08/2022 - 01/2002
13	Radiotherapy 01/2023 - 01/2002
8	Precision Medicine 01/2021 - 04/2012
5	Aftercare (After-Treatment) 01/2020 - 05/2006
4	Immunotherapy 03/2018 - 08/2002
3	Prostatectomy (Retropubic Prostatectomy) 05/2014 - 10/2004
3	Neoadjuvant Therapy 08/2013 - 04/2012
3	Thyroidectomy 06/2013 - 11/2002